Are there all-cause mortality differences between metabolic dysfunction-associated steatotic liver disease subtypes?
Authors:
- 28 July 2023
- journal article
- letter
- Published by Elsevier in Journal of Hepatology
- Vol. 80 (2) , e53-e54
Abstract
No abstract availableFunding Information
- Beijing Municipal Science and Technology Commission, Adminitrative Commission of Zhongguancun Science Park (Z191100007619037)
This publication has 7 references indexed in Scilit:
- Metabolic dysfunction‐associated fatty liver disease and excessive alcohol consumption are both independent risk factors for mortalityHepatology, 2023
- Any alcohol use in NAFLD patients is associated with significant changes to the intestinal viromeHepatology, 2023
- Ethyl glucuronide in hair detects a high rate of harmful alcohol consumption in presumed non-alcoholic fatty liver diseaseJournal of Hepatology, 2022
- Are there outcome differences between NAFLD and metabolic‐associated fatty liver disease?Hepatology, 2022
- A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statementJournal of Hepatology, 2020
- Low Thyroid Function in Nonalcoholic Fatty Liver Disease Is an Independent Predictor of All-Cause and Cardiovascular MortalityAmerican Journal of Gastroenterology, 2020
- Effects of Alcohol Consumption and Metabolic Syndrome on Mortality in Patients With Nonalcoholic and Alcohol-Related Fatty Liver DiseaseClinical Gastroenterology and Hepatology, 2019